RhumbLine Advisers’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-67,157
| Closed | -$2.31M | – | 3070 |
|
|
2020
Q3 | $2.31M | Sell |
67,157
-22,170
| -25% | -$764K | ﹤0.01% | 1595 |
|
|
2020
Q2 | $1.49M | Buy |
89,327
+11,653
| +15% | +$195K | ﹤0.01% | 1876 |
|
|
2020
Q1 | $1.12M | Buy |
77,674
+8,843
| +13% | +$128K | ﹤0.01% | 1830 |
|
|
2019
Q4 | $2.3M | Buy |
68,831
+4,941
| +8% | +$165K | ﹤0.01% | 1721 |
|
|
2019
Q3 | $1.34M | Buy |
63,890
+462
| +0.7% | +$9.68K | ﹤0.01% | 1907 |
|
|
2019
Q2 | $1.32M | Buy |
63,428
+5,975
| +10% | +$124K | ﹤0.01% | 1939 |
|
|
2019
Q1 | $1.28M | Sell |
57,453
-494
| -0.9% | -$11K | ﹤0.01% | 1917 |
|
|
2018
Q4 | $1.39M | Buy |
57,947
+18,916
| +48% | +$452K | ﹤0.01% | 1855 |
|
|
2018
Q3 | $1.07M | Sell |
39,031
-2,700
| -6% | -$73.7K | ﹤0.01% | 1981 |
|
|
2018
Q2 | $1.12M | Buy |
41,731
+8,348
| +25% | +$224K | ﹤0.01% | 1956 |
|
|
2018
Q1 | $1.06M | Sell |
33,383
-480
| -1% | -$15.3K | ﹤0.01% | 1915 |
|
|
2017
Q4 | $1.28M | Sell |
33,863
-6,287
| -16% | -$238K | ﹤0.01% | 1841 |
|
|
2017
Q3 | $995K | Buy |
40,150
+590
| +1% | +$14.6K | ﹤0.01% | 1981 |
|
|
2017
Q2 | $813K | Buy |
39,560
+9,928
| +34% | +$204K | ﹤0.01% | 2054 |
|
|
2017
Q1 | $644K | Buy |
29,632
+995
| +3% | +$21.6K | ﹤0.01% | 2148 |
|
|
2016
Q4 | $586K | Buy |
28,637
+3,030
| +12% | +$62K | ﹤0.01% | 2137 |
|
|
2016
Q3 | $384K | Buy |
25,607
+4,407
| +21% | +$66.1K | ﹤0.01% | 2357 |
|
|
2016
Q2 | $229K | Buy |
21,200
+10,520
| +99% | +$114K | ﹤0.01% | 2670 |
|
|
2016
Q1 | $145K | Buy |
+10,680
| New | +$145K | ﹤0.01% | 2827 |
|